Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and Hyperlipemia

resveratrol has been researched along with Hyperlipemia in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's7 (70.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Z; Han, HP; He, JP; Xie, HC1
Chen, W; Fan, S; Jin, X; Wang, L; Xie, X; Xue, N1
Ahmed, A; Ayo, JO; Jimoh, A; Mohammed, A; Tanko, Y1
Asmis, R; Ullevig, SL; Zamora, D; Zhao, Q1
He, XH; Jia, HY; Li, W; Shi, WG; Zhong, BH1
Das, DK; Fujitaka, K; Iwasaka, T; Iwasaki, M; Jo, F; Jo, H; Nishikawa, M; Nomura, E; Otani, H1
Cho, SJ; Choi, MS; Jung, UJ1
Kimura, Y1
Aubin, MC; Calderone, A; Clément, R; Gosselin, H; Lajoie, C; Perrault, LP1
Miura, Y; Nihei, T; Yagasaki, K1

Reviews

1 review(s) available for resveratrol and Hyperlipemia

ArticleYear
Pharmacological studies on resveratrol.
    Methods and findings in experimental and clinical pharmacology, 2003, Volume: 25, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arachidonic Acid; Cell Degranulation; Chemical and Drug Induced Liver Injury; Glucosides; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipid Peroxidation; Neoplasm Metastasis; Neutrophils; Phytotherapy; Polygonum; Resveratrol; Stilbenes

2003

Trials

1 trial(s) available for resveratrol and Hyperlipemia

ArticleYear
Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.
    Nutrition research (New York, N.Y.), 2011, Volume: 31, Issue:11

    Topics: Aged; Diabetes Mellitus; Drug Compounding; Endothelium, Vascular; Female; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Life Style; Male; Metabolic Syndrome; Middle Aged; Resveratrol; Stilbenes; Vasodilation; Vasodilator Agents

2011

Other Studies

8 other study(ies) available for resveratrol and Hyperlipemia

ArticleYear
A study on the effect of resveratrol on lipid metabolism in hyperlipidemic mice.
    African journal of traditional, complementary, and alternative medicines : AJTCAM, 2014, Volume: 11, Issue:1

    Topics: Animals; Arteriosclerosis; Cholesterol; Dose-Response Relationship, Drug; Fallopia japonica; Hyperlipidemias; Lipid Metabolism; Male; Mice; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes; Triglycerides

2014
Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Animals; Bezafibrate; Cricetinae; Diet, High-Fat; Drug Design; Gene Expression Regulation; Hyperinsulinism; Hyperlipidemias; Hypolipidemic Agents; Liver; Male; Muscle, Skeletal; Pentanoic Acids; PPAR alpha; Resveratrol; Sirtuin 1; Stilbenes; Triglycerides

2014
Resveratrol Protects Rabbits Against Cholesterol Diet-Induced Hyperlipidaemia.
    Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria, 2016, Aug-30, Volume: 31, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Hyperlipidemias; Male; Protective Agents; Rabbits; Resveratrol; Stilbenes; Triglycerides

2016
Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.
    Atherosclerosis, 2011, Volume: 219, Issue:2

    Topics: Animals; Aortic Diseases; Atherosclerosis; Cardiovascular Agents; Cell Line; Chemokine CCL2; Chemotaxis, Leukocyte; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Humans; Hyperlipidemias; Kidney; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Oxidative Stress; Receptors, CCR2; Receptors, LDL; Resveratrol; Stilbenes; Time Factors; Triterpenes; Ursolic Acid

2011
Novel phenoxyalkylcarboxylic acid derivatives as hypolipidaemic agents.
    Journal of enzyme inhibition and medicinal chemistry, 2012, Volume: 27, Issue:2

    Topics: Animals; Carboxylic Acids; Cholesterol; Diabetes Mellitus, Experimental; Fenofibrate; Flavonoids; Hyperlipidemias; Hypolipidemic Agents; Magnetic Resonance Spectroscopy; Male; Mice; Models, Molecular; Molecular Structure; Polyethylene Glycols; Resveratrol; Stilbenes; Surface-Active Agents; Triglycerides

2012
Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice.
    The British journal of nutrition, 2012, Dec-28, Volume: 108, Issue:12

    Topics: Adiposity; Animals; Cholesterol; Diet; Diet, High-Fat; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acid Synthases; Fatty Liver; Glucosephosphate Dehydrogenase; Hyperlipidemias; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Phosphatidate Phosphatase; Resveratrol; Stilbenes; Triglycerides; Weight Gain

2012
Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 325, Issue:3

    Topics: Acetylcholine; Animals; Antioxidants; Aorta; Blood Pressure; Dietary Fats; Female; Fibrosis; Hyperlipidemias; Myocardium; Nitroprusside; Obesity; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Vasodilation; Vasodilator Agents; Ventricular Dysfunction, Left

2008
Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats.
    Life sciences, 2001, May-11, Volume: 68, Issue:25

    Topics: Administration, Oral; Albumins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Basement Membrane; Blood Urea Nitrogen; Body Weight; Cholesterol; Disease Models, Animal; Eating; Glomerulonephritis; Hyperlipidemias; Hypoproteinemia; Kidney; Kidney Glomerulus; Liver; Male; Organ Size; Proteinuria; Rabbits; Rats; Rats, Wistar; Resveratrol; Stilbenes; Triglycerides

2001